Bal Pharma Ltd Q1FY23 consolidated PAT falls to Rs. 28.22 lakhs

Bal Pharma Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 70.0834 crores during the period ended June 30, 2022 as compared to Rs. 77.7530 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.2822 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 1.9707 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.19 for the period ended June 30, 2022 as compared to Rs. 1.30 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 70.0834 crs	₹77.7530 crs	-9.86%
Net Profit	₹0.2822 crs	₹1.9707 crs	-85.68%
EPS	₹0.19	₹1.30	-85.38%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 70.0834 crores during the period ended June 30, 2022 as compared to Rs.70.9633 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.2822 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.1.6220 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.19 for the period ended June 30, 2022 as compared to Rs.1.09 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 70.0834 crs	₹70.9633 crs	-1.24%
Net Profit	₹0.2822 crs	₹1.6220 crs	-82.60%
EPS	₹0.19	₹1.09	-82.57%

Shares of Bal Pharma Limited was last trading in BSE at Rs. 98.05 as compared to the previous close of Rs. 98.20. The total number of shares traded during the day was 3163 in over 111 trades.

The stock hit an intraday high of Rs. 99.95 and intraday low of 97.95. The net turnover during the day was Rs. 311371.00.

Source : Equity Bulls

Keywords

BalPharma Q1FY23 ResultUpdate